•
Dec 31, 2021

Reneo Pharmaceuticals Q4 2021 Earnings Report

EPS
-$0.37
Previous year: -$43
-99.1%
Cash and Equivalents
$125M
Previous year: $53.6M
+132.5%
Free Cash Flow
-$10.1M
Previous year: -$5.43M
+86.3%
Total Assets
$154M
Previous year: $55.2M
+178.9%

Reneo Pharmaceuticals

Reneo Pharmaceuticals